PEA‑15 contributes to the clinicopathology and AKT‑regulated cisplatin resistance in gastric cancer
نویسندگان
چکیده
منابع مشابه
TRIB2 contributes to cisplatin resistance in small cell lung cancer
Small cell lung cancer (SCLC) is the most aggressive lung-cancer subtype and so far, no favorable therapeutic strategy has been established for chemo-resistant SCLC. Cisplatin is one of the most important components among all standard poly-chemotherapeutic regimens for SCLC; therefore, this study focused on revealing Cisplatin-resistance mechanism(s) in this disease. Cisplatin-resistant SCLC ce...
متن کامل1 Bim degradation contributes to cisplatin resistance
Cisplatin is the first l ine chemotherapy for the treatment of several cancers. However, the development of cisplatin resistance represents a major clinical problem and the mechanisms of acquired resistance are not fully understood. Here we show that degradation of the BH3only pro-apoptotic protein Bim plays an important role in cisplatin resistance in ovarian cancer. Specifically, we show that...
متن کاملNeuropilin-1 is associated with clinicopathology of gastric cancer and contributes to cell proliferation and migration as multifunctional co-receptors
BACKGROUND Neuropilin-1 (NRP-1) is a transmembrane glycoprotein participating in the growth and metastasis of cancer cells as multifunctional co-receptors by interacting with the signaling pathways. However, its role in gastric cancer has not yet been clarified. This study aims to investigate whether NRP-1 expression is associated with the clinicopathology of gastric cancer, and involved in the...
متن کاملThe mTORC2 Component Rictor Contributes to Cisplatin Resistance in Human Ovarian Cancer Cells
Resistance to cisplatin-based therapy is a major cause of treatment failure in human ovarian cancer. A better understanding of the mechanisms of cisplatin resistance will offer new insights for novel therapeutic strategies for this deadly disease. Akt and p53 are determinants of cisplatin sensitivity. Rictor is a component of mTOR protein kinase complex 2, which is required for Akt phosphorylat...
متن کاملUCHL1 Is a Putative Tumor Suppressor in Ovarian Cancer Cells and Contributes to Cisplatin Resistance
Ubiquitin carboxyl terminal hydrolase 1 (UCHL1) catalyzes the hydrolysis of COOH-terminal ubiquityl esters and amides. It has been reported as either an oncogene or a tumor suppressor in cancers. However, UCHL1's role in ovarian cancer is still unclear. Therefore, we conducted an analysis to understand the role of UCHL1 in ovarian cancer. Firstly, we detected UCHL1 promoter methylation status i...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Oncology Reports
سال: 2018
ISSN: 1021-335X,1791-2431
DOI: 10.3892/or.2018.6934